NEA Management Company’s Orexigen Therapeutics, Inc. OREX Stock Holding History

NEA Management Company’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-370,900	Closed	-$478K	–	46
2017 Q4	$478K	Hold	370,900	–	–	0.02%	43
2017 Q3	$786K	Hold	370,900	–	–	0.03%	41
2017 Q2	$1.08M	Hold	370,900	–	–	0.04%	42
2017 Q1	$1.28M	Hold	370,900	–	–	0.04%	35
2016 Q4	$645K	Hold	370,900	–	–	0.03%	37
2016 Q3	$1.23M	Buy	370,900 +333,810	+900%	+$1.26M	0.06%	36
2016 Q2	$1.59M	Sell	37,090 -333,810	-90%	-$1.51M	0.08%	35
2016 Q1	$2.08M	Hold	370,900	–	–	0.14%	34
2015 Q4	$6.38M	Hold	370,900	–	–	0.41%	23
2015 Q3	$7.83M	Hold	370,900	–	–	0.52%	24
2015 Q2	$18.4M	Hold	370,900	–	–	0.96%	19
2015 Q1	$29M	Hold	370,900	–	–	1.31%	16
2014 Q4	$22.5M	Hold	370,900	–	–	1.09%	20
2014 Q3	$15.8M	Buy	370,900 +177,370	+92%	+$9.52M	0.8%	23
2014 Q2	$12M	Hold	193,530	–	–	0.56%	25
2014 Q1	$12.6M	Hold	193,530	–	–	0.62%	23
2013 Q4	$10.9M	Buy	193,530 +78,000	+68%	+$4.38M	0.53%	23
2013 Q3	$7.08M	Buy	+115,530	New	+$7.82M	0.28%	27

Other funds holding OREX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NEA Management Company's OREX Position: Q1 2018 in Review

NEA Management Company sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2018, closing a stake of 370,900 shares — an estimated $478K sold.

NEA Management Company first reported a position in OREX in Q3 2013 and held it in 18 quarters. The position peaked at $29M in Q1 2015. 27 funds tracked by Wall St. Rank hold OREX as of Q1 2018.

NEA Management Company reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
NEA Management Company sold 370,900 Orexigen Therapeutics, Inc. shares in Q1 2018, an estimated $478K.
NEA Management Company first reported a position in Orexigen Therapeutics, Inc. in Q3 2013 and held it in 18 quarters.
NEA Management Company's Orexigen Therapeutics, Inc. position peaked at $29M in Q1 2015.
27 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2018.

Based on NEA Management Company's 13F filing for Q1 2018, filed 10 May 2018.